Fresenius Medical Care AG

BATS-CHIXE:FMED Stock Report

Market Cap: €12.4b

Fresenius Medical Care Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Helen Giza

Chief executive officer

€5.5m

Total compensation

CEO salary percentage30.1%
CEO tenure5yrs
CEO ownership0.005%
Management average tenure2yrs
Board average tenureless than a year

Recent management updates

Recent updates

CEO Compensation Analysis

How has Helen Giza's remuneration changed compared to Fresenius Medical Care's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

€659m

Jun 30 2024n/an/a

€530m

Mar 31 2024n/an/a

€484m

Dec 31 2023€6m€2m

€499m

Sep 30 2023n/an/a

€450m

Jun 30 2023n/an/a

€596m

Mar 31 2023n/an/a

€602m

Dec 31 2022€3m€1m

€673m

Sep 30 2022n/an/a

€763m

Jun 30 2022n/an/a

€806m

Mar 31 2022n/an/a

€878m

Dec 31 2021€2m€855k

€969m

Sep 30 2021n/an/a

€918m

Jun 30 2021n/an/a

€998m

Mar 31 2021n/an/a

€1b

Dec 31 2020€2m€855k

€1b

Sep 30 2020n/an/a

€1b

Jun 30 2020n/an/a

€1b

Mar 31 2020n/an/a

€1b

Dec 31 2019€2m€108k

€1b

Compensation vs Market: Helen's total compensation ($USD5.76M) is about average for companies of similar size in the UK market ($USD5.66M).

Compensation vs Earnings: Helen's compensation has increased by more than 20% in the past year.

CEO

Helen Giza (56 yo)

5yrs

Tenure

€5,528,000

Compensation

Ms. Helen Giza is Chief Executive Officer and Chair of the Management Board of Fresenius Medical Care Management AG, General Partner of Fresenius Medical Care AG & Co. KGAA from December 6, 2022. She serve...

Leadership Team

NamePositionTenureCompensationOwnership
Helen Giza
Chair of Management Board & CEO5yrs€5.53m0.0047%
€ 580.2k
Martin Fischer
CFO & Member of the Management Board1.1yrs€887.00kno data
Franklin Maddux
Global Chief Medical Officer & Member of Management Board4.8yrs€3.13m0.0062%
€ 766.1k
Katarzyna Mazur-Hofsab
CEO of Care Enablement & Member of Management Board2.8yrs€3.71m0.0039%
€ 479.8k
Craig Cordola
CEO of Care Delivery & Member of Management Boardless than a yearno datano data
Dominik Heger
Executive VP and Head of Investor Relationsno datano datano data
Jorg Haring
Global Head of Legalless than a yearno datano data
Joachim Weith
Senior Vice President of Corporate Communications & Governmental Affairsno datano datano data
Gail-Suzanne Brown
Senior Vice President of Research & Developmentno datano datano data
Glenn Slater
Senior Vice President of Manufacturing and Supply Chain Operationsno datano datano data
Wolfgang Kummerle
Senior Vice President - Quality Management Internationalno datano datano data
Thomos Dimt
Executive Vice President of Western Europe & Nephrocare Coordination EMEALAno datano datano data

2.0yrs

Average Tenure

56.5yo

Average Age

Experienced Management: FMED's management team is not considered experienced ( 2 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Shervin Korangy
Independent Member of Supervisory Boardless than a year€20.00kno data
Michael Sen
Chairman of the Supervisory Board1.3yrs€444.00kno data
Marcus Kuhnert
Independent Member of Supervisory Boardless than a year€21.00kno data
A. Sorensen
Independent Member of Supervisory Board3.5yrs€151.00kno data
Stefanie Balling
Employee Representative Deputy Chairwoman of the Supervisory Boardless than a yearno datano data
Sara Hennicken
Member of Supervisory Boardless than a year€158.00kno data
Frank Prescher
Employee Representative Member of Supervisory Boardless than a yearno datano data
Regina Karsch
Employee Representative Member of the Supervisory Boardless than a yearno datano data
Manuela Grabo
Employee Representative Member of the Supervisory Boardless than a yearno datano data
Ralf Erkens
Employee representatives Member of the Supervisory Boardless than a yearno datano data
Beate Habdenteufel
Employee representatives Member of the Supervisory Boardless than a yearno datano data

0.8yrs

Average Tenure

56yo

Average Age

Experienced Board: FMED's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.